供应商 · 生产商 · 工业生物技术与生物基材料

SyncoZymes (Shanghai)

Syncozymes 是中国绿色工艺化学与生物转化领域的领先企业，专注原料药（API）及中间体的研发、开发与生产；公司位于上海国际医学园区，主营酶的研发、发酵、固定化、蛋白质工程与应用，以及原料药和中间体的研发生产、合成设计与工艺设计优化。Syncozymes 是中国首家且规模最大的商业化生产辅酶 NAD、NADP、NADH 和 NADPH 的企业。客户与伙伴包括美国、欧洲、印度和中国的顶级制药公司；管理团队在美中两国顶级制药和生物技术公司拥有合计 30 余年领导经验，科学团队汇聚发酵、酶研发、蛋白质工程与纯化、药物化学、工艺化学、绿色化学和工业生物转化领域的领先专家。

运营中中国亚洲成立 2007 核实于 2026-10-05

简介

SyncoZymes (Shanghai) Co., Ltd. is a biotechnology company specializing in green pharmaceutical technology, biocatalysis, and synthetic biology. It provides enzymes, co-enzymes (including NMN, NAD, NADP, NADH, and NADPH), functional food raw materials, and pharmaceutical intermediates, while offering CRO and CDMO services.

Founded in 2007 and headquartered in the Shanghai International Medical Park, the company operates as a wholly-owned subsidiary of Zhejiang SyncoZymes Bio-pharmaceutical Co., Ltd. It maintains a large enzyme library of over 10,000 enzymes and operates GMP-compliant production facilities with an annual capacity exceeding 1,200 tons for enzymes and co-enzymes. The company remains active as of September 2026.

Sources#

行业: 食品配料, 工业化学
主题: 酶与生物催化, 维生素、类胡萝卜素与保健活性成分
角色: 生产商 — “…d GMP production. - R&D and Manufacturing Platform: Strong biotech and chemical technology platforms, GMP prod…”

供应的生物解决方案 3

D3	以发酵法生产维生素（B2、B12、C 路线），替代多步化学合成
D1	以生物基粘合剂和生物溶剂替代涂料中的石化树脂和 VOC 溶剂体系
D2	工业生物催化（酶和全细胞）——如腈水合酶生产丙烯酰胺、工程转氨酶生产西格列汀、酶法抗生素侧链工艺——替代重金属催化剂、高压加氢和使用有毒试剂的多步化学反应

产品与服务

产品: bioenzymes; co-enzyme of NAD series products; functional food raw materials; pharmaceutical intermediates; Enzymes; Co-enzymes; CRO/CDMO Services; Testing and Quality Research Services; Technical Support; Formulation

应用: Pharmaceutical industry · Health industry · Functional food sector
生产基地: Shanghai · Pudong New Area, Shanghai · Pudong New Area, Shanghai — More than 600 tons per year for intermediates, 100 tons/year for coenzymes.; Co-enzymes, Enzymes, Intermediates · Shanghai Pudong Zhangjiang High-tech Park
产品（官网）: bioenzymes · co-enzyme of NAD series products — including NMN, NAD, NADP, NADH, NADPH · functional food raw materials · pharmaceutical intermediates · Enzymes · Co-enzymes · Functional Food Raw Materials · Pharmaceutical Intermediates · CRO/CDMO Services · Testing and Quality Research Services · Technical Support · Co-enzymes — Production system includes 500L, 1000L, 2000L, 5000L reaction kettles and related facilities.
研发设施: More than 2,000 square meters of laboratories

摘自公司官网: about · products · production · quality · rnd · leadership · contact · sustainability

新闻与状态 6

2025-09-30 喜讯！FDA确认NMN可作为膳食补充剂，NDI 恢复迎来转机_尚科生物医药（上海）有限公司
SyncoZymes (Shanghai) (尚科生物医药（上海）有限公司) reports that the FDA has now recognized NMN as a legal ingredient for dietary supplements, marking a turning point for NMN’s global market access. The company highlights its GMP-produced NMN with milestone approvals (NDI …
2026-08-27 Longevity Life Sciences and SyncoZymes deepen strategic biotechnology partnership | LLS
SyncoZymes (Shanghai) Co Ltd is the manufacturing partner behind CellVive NMN, with an R&D center in Shanghai and a Zhejiang production site, producing enzymes and coenzymes (including NMN, NAD, NADH, NADP) and claiming annual NMN/NADH/NAD coenzyme production …
2025-12-19 Chinese Company Drives Global NMN Regulatory Breakthroughs in the U.S. and Australia - ZMUni Compliance Centre
2026-04-15 NMN 500mg Energy Support Gets TGA Approval in Australia
SyncoZymes (Shanghai) Co Ltd is the primary sponsor under Australia’s TGA restricted authorization for NMN products until December 10, 2027, enabling it to oversee sales during that period and allowing other companies to obtain permission to sell NMN through …
2025-12-31 Global Regulatory Progress of NMN in the US, Australia and the EU - Regulatory News - Food & Food Contact Materials - CIRS Group
SyncoZymes (Shanghai) Co., Ltd. produced NMN that became the first NMN ingredient to receive an U.S. NDI notification (NDI No. 1247) in May 2022, but the FDA initially rejected a later NDI (No. 1259) and withdrew SyncoZymes’ NDI acknowledgement. By December …
2025-12-20 Australia regulator approves NMN ingredient for supplement use - Israel News Beep | NewsBeep.com
SyncoZymes, a Shanghai-based company, manufactured the NMN ingredient (CellVive NMN) approved by Australia’s TGA for use in supplements. The approval notes SyncoZymes as the manufacturing partner, and the company was also among NMN producers cited in a U.S. …

关系网络：股东、合作伙伴、同类

股权与投资方 1

母公司	SyncoZymes

合作与交易 2

交易对手	SyncoZymes (Zhejiang) Co
交易对手	Ltd. (parent company)

身份与联系方式

联系方式、人员和法律信息仅向会员开放。

会员登录